Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 12/2016

01-12-2016 | Original article

RETRACTED ARTICLE: Diagnostic and prognostic potentials of KLF6 and HER3 expression alterations in cutaneous malignant melanoma

Authors: Ali Ebrahimi, Seyed Mohamad Hossein Tabatabaei Nodushan, Alireza Mousavian, Aram Mokarizadeh, Mehdi Abbasi, Emad Yahaghi, Seyed Mohammad Rasaei

Published in: Tumor Biology | Issue 12/2016

Login to get access

Excerpt

RETRACTED ARTICLE: Tumor Biol. …
Appendix
Available only for authorised users
Metadata
Title
RETRACTED ARTICLE: Diagnostic and prognostic potentials of KLF6 and HER3 expression alterations in cutaneous malignant melanoma
Authors
Ali Ebrahimi
Seyed Mohamad Hossein Tabatabaei Nodushan
Alireza Mousavian
Aram Mokarizadeh
Mehdi Abbasi
Emad Yahaghi
Seyed Mohammad Rasaei
Publication date
01-12-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4236-y

Other articles of this Issue 12/2016

Tumor Biology 12/2016 Go to the issue

Review

The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis

Original Article

Notch3 negatively regulates chemoresistance in breast cancers

Original Article

A novel model for identification of prognostic indicator for clinical outcome of squamous cell lung carcinoma

Original Article

HCRP1 is downregulated in non-small cell lung cancer and regulates proliferation, invasion, and drug resistance

Original Article

RETRACTED ARTICLE: Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144

Original Article

E2F-1 promotes DAPK2-induced anti-tumor immunity of gastric cancer cells by targeting miR-34a
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits